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 Two studies at the Jefferson  
Vascular Center (JVC) are assessing 
innovative methods to reduce risk of 
complications — and increase positive 
outcomes — for vascular surgery 
patients. Here, Paul DiMuzio, MD, 
FACS, William M. Measey Professor  
of Surgery and Co-Director, Jefferson 
Vascular Center, reviews what both 
studies mean for patient care.
‘Game-changer’ for groin wounds
As Dr. DiMuzio explains, groin incisions 
in vascular surgery are a source of 
significant morbidity and healthcare 
costs. When groin wounds become 
infected, patients may have to be 
readmitted and undergo additional 
surgery. Some patients are at greater 
risk because of diabetes and obesity, 
others because of the surgical 
technique required for their treatment. 
In exploring ways to decrease groin 
wound infections in high-risk patients, 
the JVC identified a possible solution 
in PrevenaTM — a sponge covered  
in adhesive that attaches to a small 
suction device. The suction device 
removes fluids from the region, 
helping reduce the risk of infection. 
Already FDA-approved, Prevena is 
used by cardiac surgeons for sternal 
incisions and by orthopedic surgeons 
in total joint replacements. 
“No one had conducted a prospective 
randomized trial to determine if 
Prevena is a viable option for high-
risk groin wounds,” he says. “We  
were the first.”
The results of Jefferson’s two-year 
study — which will be presented  
later this Spring at the 2017 Annual 
Meeting of the Society for Vascular 
Surgery in San Diego — showed a 
significant reduction in infections  
and re-admissions. Hospital costs 
declined by an average of $6,000  
per patient. 
We are now using [the 
Prevena] device for every 
patient with high-risk 
groin incisions, and  
we expect it to become  
a standard of care 
everywhere once the 
findings are published.
“We are now using this device for 
every patient with high-risk groin 
incisions, and we expect it to become 
a standard of care everywhere once 
the findings are published,” he adds. 
“It’s a game changer.”
In February, Megan Lundgren, MD,  
a third-year General Surgery resident 
and Sidney Kimmel Medical College 
alumna, presented the study at the 
Philadelphia Academy of Surgery’s 
Annual Surgical Research Competition. 
Dr. Lundgren, who helped enroll and 
care for trial participants, won the 
inaugural Chris Tzarnas Surgical 
Research Award for the work.
Follow-up trial of new treatment  
for carotid artery disease
Following the promising multi-center 
ROADSTER trial, the ROADSTER 2 trial 
is observing and evaluating real-world 
results of a newly approved procedure 
for treating carotid artery disease.
The most widely used treatment  
for carotid artery disease has been 
the carotid endarterectomy (CEA) 
procedure, in which plaque is surgically 
removed from the blocked artery.  
For patients who may be at high 
medical or anatomic risk for carotid 
endarterectomy, carotid stenting  
may be a better option. Though both 
procedures are generally safe, heart 
attack risk is higher with CEA, while 
stroke risk is higher with stenting. 
Trans-carotid Artery Revascularization 
(TCAR) is designed to lower both 
risks, and the initial ROADSTER trial 
demonstrated its success.
“The TCAR procedure is a hybrid  
of the other two treatments,” Dr. 
DiMuzio says. “It places a carotid 
stent through a minimally invasive 
incision in the carotid artery at the 
level of the neck. Blood flow in  
the artery is temporarily reversed  
to protect the brain from plaque 
fragments that may come loose 
during the procedure. A stent is then 
inserted into the blood vessel to 
support the artery walls and prevent 
blockage or collapse.” Dr. DiMuzio 
adds that stent deployment via access 
directly through the common carotid 
artery avoids the need to traverse the 
aortic arch with catheters, which can 
lead to embolic stroke. 
Though approved by the FDA,  
the TCAR procedure will not be 
marketed until the ROADSTER 2 trial 
is completed. To date, Jefferson is 
the first and only study location in  
the Philadelphia area. Dr. DiMuzio  
and his team have already performed 
the TCAR procedure and are actively 
enrolling more patients.
“Nationally, the study is more than 
halfway to completion — and the 
TCAR procedure is on its way to 
becoming an exciting new standard 
of care for carotid artery disease,”  
he says.
For more information, contact  
the Jefferson Vascular Center  
at 215-955-8304 or visit  
Jefferson.edu/JVC.
For an appointment with a Jefferson Surgeon, call 1-800-JEFF-NOW
Changing Lives Through Research
Since joining the Department of Surgery 
in 2001 as an administrative assistant in 
the Division of Transplant Surgery, Andrea 
DelMastro has moved to our 1300 Wolf Street 
Office on the Methodist Campus. Born and 
raised in South Philly, she has returned and 
served as the Department’s practice manager 
there for the past five years. 
At Methodist, Andrea oversees day-to-day 
operations of 14 providers and a team of 
registrars, medical assistants and nurse 
practitioners. The practice includes several 
specialties within the Department of Surgery: 
Bariatric, Breast, Colorectal, General, Thoracic 
and Vascular Surgery & Vascular Medicine. 
The services provided there include more than 
just surgical consultations, as several other 
outpatient services are offered, including 
vascular ultrasound, minimally invasive vein 
closure, and wound care.
During the last few years she has been 
active at both campuses taking on a number 
of departmental projects: she is currently 
the Department’s lead for the JeffConnect 
telehealth program and serves as a ‘super 
user’ for the EPIC Electronic Health Record 
implementation. 
Another of DelMastro’s long-term projects 
is contributing to the Methodist Hospital 
Division’s Surgery White Paper. The purpose 
of the ongoing initiative: to identify ways to 
improve both patient experience and overall 
surgical patient throughput at Methodist. 
To date, such improvements have included 
adding a room for private family surgical 
consultations and staffing a patient registrar.
She appreciates the diverse challenges of  
her work: “Every day is different,” she says.  
“I juggle clinic hours, department projects, as 
well as the unique needs of staff and patients 
that come up daily.” DelMastro strives to 
make sure her employees are engaged, as  
she believes that “makes all the difference  
in patient care.”
Above all, Andrea values being part of the 
Methodist community: “I love that I get to 
work in an office where I know the majority 
of my patients from the neighborhood. It’s 
world-class care – with a real hometown feel.” 
The Jefferson Vascular Center surgeons, Drs. Paul DiMuzio, Dawn Salvatore and Babak Abai, rely on the support of 
advanced practice nurses Meghan McCullough, MSN, RN, FNP, AGACNP, and Cara Staley, MSN, RN-BC, AGACNP-BC 
(on either side of Dr. Salvatore) to manage the Prevena and ROADSTER 2 clinical trials.
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